INTEL//MAPGLOBAL OSINT WATCH
LANG · RAW
humanitarian

Referral: Rifadin oral suspension and syrup and associated names, rifampicin Article 31 referrals Procedure started, 15/10/2026

Referral: Rifadin oral suspension and syrup and associated names, rifampicin Article 31 referrals Procedure started, 15/10/2026

Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

2 reports · 2 sources

EMA What Is NewReferral: Rifadin oral suspension and syrup and associated names, rifampicin Article 31 referrals Procedure started, 15/10/2026EMA What Is NewReferral: Rifadin oral suspension and syrup and associated names, rifampicin Article 31 referrals Procedure started, 15/10/2026
INCIDENT EVOLUTION

2 recorded states

Signal first indexedP2 · 92% quality · 2 sources

Quality 92→99P2 · 99% quality · 2 sources

Explore this day in the archive →
Related intelligence

More in humanitarian

Times of India · 16:49 UTC

Flat redeveloped, man sells in 8 days for Rs 1.95 cr; gets notice, ITAT gives relief

Open brief → Arab News · 15:34 UTC

Praise for Saudi airport worker who guided passengers to safety during Riyadh attack

Open brief → EMA What Is New · 14:25 UTC

Human medicines European public assessment report (EPAR): Optruma, raloxifene, Date of authorisation: 05/08/1998, Revision: 28, Status: Withdrawn

Open brief → EMA What Is New · 14:23 UTC

PSUSA/00001694/202603

Open brief →
QUALITY CONTROL

Report this signal

Reports are anonymous and retained privately for editorial review.